Teresa Macarulla
0000-0002-5856-4082
Publication & Citation Trends
Publications
703 total
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With <i>IDH1</i> Mutation PDF
Cited by 452
OpenAlex
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study PDF
Cited by 1,034
OpenAlex
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Cited by 515
OpenAlex
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer PDF
Cited by 2,150
OpenAlex
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Cited by 709
OpenAlex
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Cited by 1,175
OpenAlex
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Cited by 1,376
OpenAlex
Research Topics
Pancreatic and Hepatic Oncology Research
(299)
Cancer Genomics and Diagnostics
(164)
Cholangiocarcinoma and Gallbladder Cancer Studies
(145)
Colorectal Cancer Treatments and Studies
(134)
Neuroendocrine Tumor Research Advances
(67)
Affiliations
Universitat de Vic - Universitat Central de Catalunya
Hebron University
Universitat Autònoma de Barcelona
Novartis (Switzerland)
Translational Genomics Research Institute